Physician profile
Oscar B Jackson, JR.
NPI 1215019278
$3,125.15
in general payments reported to CMS, 2019-2025
18 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2021: $223 · 2022: $578 · 2023: $659 · 2024: $754 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614 · Entertainment: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.93 |
| Entertainment | $144.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.20 | 2022-2025 | |
| Regeneron Pharmaceuticals, INC. | $284.95 | 2022-2023 | Eylea Hd |
| Genentech USA, INC. | $268.20 | 2022-2023 | Vabysmo |
| Optos, INC. | $243.10 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Aerie Pharmaceuticals, INC. | $239.95 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $227.29 | 2023-2024 | Tecnis Simplicity |
| New World Medical,INC. | $199.65 | 2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Glaukos Corporation | $165.84 | 2024 | |
| Sight Sciences, INC. | $149.94 | 2024 | Omni Surgical System |
| Rxsight INC | $127.22 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Ocular Therapeutix, INC. | $124.44 | 2021 | |
| Apellis Pharmaceuticals, INC. | $121.52 | 2024 | Syfovre |
| Mallinckrodt Enterprises LLC | $119.31 | 2019 | |
| Amgen INC. | $114.43 | 2025 | Tepezza |
| Bausch & Lomb Americas INC. | $107.91 | 2025 | Envista Mx60 Iol |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $105.93 | 2019 | |
| Allergan, INC. | $103.27 | 2022 | |
| Optovue, INC. | $100.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.